| Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
|---|
| 06/22/2006 | US20060134198 Pharmaceutical compositions with improved dissolution |
| 06/22/2006 | US20060134194 Formulations containing substituted imidazole derivatives |
| 06/22/2006 | US20060134184 At least partially degradable films containing an active ingredient and method for the production of composition comprising an active compound |
| 06/22/2006 | US20060134181 Novel chocolate composition as delivery system for nutrients and medications |
| 06/22/2006 | US20060134180 Encapsulated polyunsaturated fatty acids |
| 06/22/2006 | US20060134179 Health food product |
| 06/22/2006 | US20060134178 Composition containing organic substance having double bond with improved oxidative stability |
| 06/22/2006 | US20060134167 Administering to the cardiac tissue an angiogenic thrombin derivative peptide and/or inhibiting vascular occulsion or restenosis and stimulating revascularization |
| 06/22/2006 | US20060134148 Aqueous sustained-release drug delivery system for highly water-soluble electrolytic drugs |
| 06/22/2006 | US20060134146 pyrazine carboxamide compounds of sub-micron size; improve bioavailibility/absorption, exhibit no increase in size upon storage in the aqueous medium; N-(1-piperidinyl)-5,6-diphenyl-2-pyrazinecarboxamide; using a precipitation process without the need for water-immiscible solvent; obesity |
| 06/22/2006 | US20060134145 Propofol-containing fat emulsions |
| 06/22/2006 | US20060134144 Mucoadhesive composition and formulation for solubilization of insoluble drugs and preparation method thereof |
| 06/22/2006 | US20060134143 Poly-gamma-glutamic conjugates for eliciting immune responses directed against bacilli |
| 06/22/2006 | US20060134140 Compositions and methods for treating tumor spreading |
| 06/22/2006 | US20060134134 Method of obatining cochlear structures, vaccine compositions, adjuvants and interme- diates thereof |
| 06/22/2006 | US20060134132 Protective barriers for micronutrients, phytochemicals, and nutraceuticals |
| 06/22/2006 | US20060134130 Oral drug delivery compositions and methods |
| 06/22/2006 | US20060134123 Comprise the gene of interest and a viral capsid or envelope carrying a member of a specific binding pair, the counterpart of which is not directly associated with the surface of the target cell; used in gene therapy |
| 06/22/2006 | US20060134095 Antioxidative composition and composition for external use |
| 06/22/2006 | US20060134086 Targeted enzymes |
| 06/22/2006 | US20060134084 Therapeutic platelets and methods |
| 06/22/2006 | US20060134069 Erythrocytic cells and method for preserving cells |
| 06/22/2006 | US20060134061 Bisacyloxypropylcysteine conjugates and the use thereof |
| 06/22/2006 | US20060134039 Nail restructuring compositions for topical application |
| 06/22/2006 | US20060134006 Chemical carrier based on a beta-limit dextrin |
| 06/22/2006 | CA2767026A1 Protein formulation for administering an active enamel substance |
| 06/22/2006 | CA2591419A1 Water-dispersible xanthan gum containing composition |
| 06/22/2006 | CA2591087A1 Method for treatment of hiv infection |
| 06/22/2006 | CA2590119A1 Anti-aging methods and composition |
| 06/22/2006 | CA2589975A1 Releasable polymeric conjugates based on aliphatic biodegradable linkers |
| 06/22/2006 | CA2589889A1 Therapeutic formulations of keratinocyte growth factor |
| 06/22/2006 | CA2588943A1 Medical tape preparation |
| 06/22/2006 | CA2587589A1 Engineered antibodies and immunoconjugates |
| 06/22/2006 | CA2587213A1 Manufacture process of n-substituted salicylamides |
| 06/22/2006 | CA2509083A1 A medical device |
| 06/21/2006 | EP1672025A1 Finely particulate composite containing carbon compound encapsulated therein |
| 06/21/2006 | EP1671654A2 Conjugates of hydroxyalkyl starch and an active agent |
| 06/21/2006 | EP1671653A1 Process for preparing an alpha lipoic acid/cyclodextrin complex and product prepared |
| 06/21/2006 | EP1671652A1 Use of chitosan for the treatment of pruritus |
| 06/21/2006 | EP1671638A1 Disphosphonate solutions |
| 06/21/2006 | EP1671625A1 Nanoparticles |
| 06/21/2006 | EP1671549A2 Method for enhancing exercise performance and recovery |
| 06/21/2006 | EP1670893A2 Immunogenic hiv compositions and related methods |
| 06/21/2006 | EP1670838A1 Amphiphilic block copolymer and polymeric composition comprising the same for drug delivery |
| 06/21/2006 | EP1670823A1 Chimeric mhc protein and oligomer thereof for specific targeting |
| 06/21/2006 | EP1670718A2 Subtituted fullerene compositions and their use as antioxydants |
| 06/21/2006 | EP1670516A2 Water soluble nanoparticles inclusion complexes |
| 06/21/2006 | EP1670513A2 Use of cox-2 inhibitor to prevent t-cell anergy induced by dendritic cell therapy |
| 06/21/2006 | EP1670500A2 Compositions capable of facilitating penetration across a biological barrier |
| 06/21/2006 | EP1670487A1 Therapeutic formulations |
| 06/21/2006 | EP1670449A2 Thyroid hormone analogs and methods of use in angiogenesis |
| 06/21/2006 | EP1670433A1 Transdermal pharmaceutical formulation for minimizing skin residues |
| 06/21/2006 | EP1670428A2 G-csf transferrin fusion proteins |
| 06/21/2006 | EP1536822B1 Stable pharmaceutical composition comprising erythropoietin |
| 06/21/2006 | EP1515705B1 Fluorosiloxane matrix controlled diffusion drug delivery system |
| 06/21/2006 | EP1448753B1 Conditioning solution for contact lenses |
| 06/21/2006 | EP1437126B1 Compositions used to alleviate xerostomia and to treat disorders associated with same |
| 06/21/2006 | EP1434589A4 Thioester-terminated water soluble polymers and method of modifying the n-terminus of a polypeptide therewith |
| 06/21/2006 | EP1423147B1 Prostaglandin compositions and methods of treatment for male erectile dysfunction |
| 06/21/2006 | EP1392325B1 Method of administration of bisphosphonates by inhalation in the treatment or prevention of bone resorption and osteoporosis |
| 06/21/2006 | EP1343526B1 Vaccine for the treatment of nicotine addiction |
| 06/21/2006 | EP1329221B1 Polymeric micelle containing cisplatin enclosed therein and use thereof |
| 06/21/2006 | EP1326595B1 Pharmaceutical composition comprising resveratrol for treating inflammatory respiratory disorders |
| 06/21/2006 | EP1315477B1 Dry powder film-coating composition and methods of manufacturing |
| 06/21/2006 | EP1267866B1 The treatment of respiratory diseases |
| 06/21/2006 | EP1265617B1 Novel topical oestroprogestational compositions with systemic effect |
| 06/21/2006 | EP1150569B1 Method for reducing hip joint laxity |
| 06/21/2006 | EP1140170B1 Antibody fragments for the topical treatment of ocular diseases |
| 06/21/2006 | EP1128835B1 Cyanocobalamin (vitamin b 12) treatment in allergic disease |
| 06/21/2006 | EP0941039A4 Transdermal administration of ment |
| 06/21/2006 | EP0932626B1 G protein-coupled receptor antagonists |
| 06/21/2006 | EP0912198B1 Immunoliposomes that optimize internalization into target cells |
| 06/21/2006 | EP0909564B1 Erythropoietin solution preparation stabilized with amino acids |
| 06/21/2006 | EP0876165B1 Crosslinked polymer compositions and methods for their use |
| 06/21/2006 | EP0754231B1 Peptide fragment of the respiratory syncytial virus g protein, immunogenic agent, pharmaceutical composition containing same, and preparation method |
| 06/21/2006 | CN1791432A Vaccine composition comprising iron phosphate as a pharmaceutical aid to said vaccine |
| 06/21/2006 | CN1791431A Micro-cluster compositions |
| 06/21/2006 | CN1791424A Sustained-release fine granular preparation of human growth hormone and process for producing the same |
| 06/21/2006 | CN1791383A Self-emulsifying compositions, methods of use and preparation |
| 06/21/2006 | CN1791378A Antifungal nail coat and method of use |
| 06/21/2006 | CN1789341A Black iron oxide pigments with high tinting strength, resistivity towards reduction and oxidation for colouring polymers and building materials |
| 06/21/2006 | CN1789278A Osteoporosis resistant estrogen-RGD peptide conjugate and its application in medicine |
| 06/21/2006 | CN1788735A Use of bioactive composition derived from cattle urine distillate ('Go-mutra') as anti-infective,anti-tumour and biological intensifier of nutriment |
| 06/21/2006 | CN1788721A Injectable buprenorphine microparticle compositions and their use |
| 06/21/2006 | CN1260294C PH responsive biodegradable polylactic acid derivatives forming polymeric micelles and uses thereof for poorly water soluble drug delivery |
| 06/21/2006 | CN1260004C Polytype Mg-Al hydrotalcite |
| 06/21/2006 | CN1259920C Biologically active agents and drugs |
| 06/21/2006 | CN1259918C Use of bile acid or bile salt fatty acid conjugates |
| 06/21/2006 | CN1259910C Liquid drug preparations |
| 06/21/2006 | CN1259909C Medicinal composition containing 2,2-dichloro-12-(4-chlorophenyl)dodecanoic acid |
| 06/21/2006 | CN1259906C Ambroxol hydrochloride containing hydroxypropyl beta-cyclodextrin and its preparation |
| 06/21/2006 | CN1259903C Slow release bioadhesive buccal tablet |
| 06/21/2006 | CN1259902C Process for producing nanoparticles of paclitaxel and albumin |
| 06/20/2006 | US7064217 2-Aminoacetamide derivatives with hydroxy-, phosphonate-, and/or methylene phosphonate substituent; antitumor, anticoagulant, antiproliferative, and wound healing agents |
| 06/20/2006 | US7064185 Antibody for human Cyr61 |
| 06/20/2006 | US7064109 Pharmaceutical composition based on macrolides for topical application in ophthalmology |
| 06/20/2006 | US7064108 Topical ivermectin composition |
| 06/20/2006 | US7063864 Morphine sulphate microgranules, method for preparing same and compositions containing same |
| 06/20/2006 | US7063863 Drug binded to polysaccharide, dextran; sustained release |
| 06/20/2006 | US7063858 Sweet with a rough texture intended for the treatment of halitosis |